-
1
-
-
0035972896
-
Controversial issues in climacteric medicine (I) Cardiovascular disease and hormone replacement therapy. International Menopause Society Expert Workshop, 13-16 October 2000, Royal Society of Medicine, London, UK
-
Genazzani A.R. Controversial issues in climacteric medicine (I) Cardiovascular disease and hormone replacement therapy. International Menopause Society Expert Workshop, 13-16 October 2000, Royal Society of Medicine, London, UK. Maturitas. 38:2001;263-271.
-
(2001)
Maturitas
, vol.38
, pp. 263-271
-
-
Genazzani, A.R.1
-
2
-
-
0035857351
-
-
Osteoporosis prevention, diagnosis, and therapy. JAMA. 285:2001;785-795.
-
(2001)
JAMA
, vol.285
, pp. 785-795
-
-
-
3
-
-
0035961202
-
Breast cancer: Hormones and other risk factors
-
Hulka B.S., Moorman P.G. Breast cancer hormones and other risk factors . Maturitas. 38:2001;103-113.
-
(2001)
Maturitas
, vol.38
, pp. 103-113
-
-
Hulka, B.S.1
Moorman, P.G.2
-
5
-
-
0035066594
-
Urogenital atrophy: Prevention and treatment
-
Willhite L.A., O'Connel M.B. Urogenital atrophy prevention and treatment . Pharmacotherapy. 21:2001;464-480.
-
(2001)
Pharmacotherapy
, vol.21
, pp. 464-480
-
-
Willhite, L.A.1
O'Connel, M.B.2
-
6
-
-
0034994194
-
Hormone replacement therapy and the endometrium
-
Feeley K.M., Wells M. Hormone replacement therapy and the endometrium. J Clin Pathol. 54:2001;435-440.
-
(2001)
J Clin Pathol
, vol.54
, pp. 435-440
-
-
Feeley, K.M.1
Wells, M.2
-
7
-
-
0034876551
-
Current perspectives on benefits and risks of hormone replacement therapy
-
Burkman R.T., Collins J.A., Greene R.A. Current perspectives on benefits and risks of hormone replacement therapy. Am J Obstet Gynecol. 185:2001;S13-S23.
-
(2001)
Am J Obstet Gynecol
, vol.185
-
-
Burkman, R.T.1
Collins, J.A.2
Greene, R.A.3
-
8
-
-
0030071199
-
The clinical aspects of estrogen and the cardiovascular system
-
Sullivan J.M., Fowlkes L.P. The clinical aspects of estrogen and the cardiovascular system. Obstet Gynecol. 87:(Suppl 2):1996;S36-43.
-
(1996)
Obstet Gynecol
, vol.87
, Issue.SUPPL. 2
, pp. 36-43
-
-
Sullivan, J.M.1
Fowlkes, L.P.2
-
9
-
-
0032547326
-
Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin replacement Study (HERS) Research Group
-
Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin replacement Study (HERS) Research Group. JAMA. 280:1998;605-613.
-
(1998)
JAMA
, vol.280
, pp. 605-613
-
-
Hulley, S.1
Grady, D.2
Bush, T.3
Furberg, C.4
Herrington, D.5
Riggs, B.6
Vittinghoff, E.7
-
10
-
-
0029785626
-
Hormone replacement therapy: Clinical benefits and side-effects
-
De Lignieres B. Hormone replacement therapy clinical benefits and side-effects . Maturitas. 23:1996;S31-36.
-
(1996)
Maturitas
, vol.23
, pp. 31-36
-
-
De Lignieres, B.1
-
11
-
-
0024853056
-
Preventive effects of transdermal administration of 17 beta-estradiol on postmenopausal bone loss: A 2-year prospective study
-
Ribot C., Tremollieres F., Pouilles J.M., Louvet J.P., Peyron R. Preventive effects of transdermal administration of 17 beta-estradiol on postmenopausal bone loss a 2-year prospective study . Gynecol Endocrinol. 3:1989;259-267.
-
(1989)
Gynecol Endocrinol
, vol.3
, pp. 259-267
-
-
Ribot, C.1
Tremollieres, F.2
Pouilles, J.M.3
Louvet, J.P.4
Peyron, R.5
-
12
-
-
0033690880
-
Esterified estrogen therapy in postmenopausal women. Relationships of bone marker changes and plasma estradiol to BMD changes: A two-year study
-
Watts N.B., Nolan J.C., Brennan J.J., Yang H.M. Esterified estrogen therapy in postmenopausal women. Relationships of bone marker changes and plasma estradiol to BMD changes a two-year study . Menopause. 7:2000;375-382.
-
(2000)
Menopause
, vol.7
, pp. 375-382
-
-
Watts, N.B.1
Nolan, J.C.2
Brennan, J.J.3
Yang, H.M.4
-
13
-
-
0022387720
-
Treatment of hot flashes with transdermal estradiol administration
-
Steingold K.A., Laufer L., Chetkoski R.J., DeFazio J.D., Matt D.W., Meldrum D.R., et al. Treatment of hot flashes with transdermal estradiol administration. J Clin Endocrinol Metab. 61:1985;627-632.
-
(1985)
J Clin Endocrinol Metab
, vol.61
, pp. 627-632
-
-
Steingold, K.A.1
Laufer, L.2
Chetkoski, R.J.3
DeFazio, J.D.4
Matt, D.W.5
Meldrum, D.R.6
-
14
-
-
0028142397
-
Determinants of coronary artery reactivity in premenopausal female cynomolgus monkeys with diet-induced atherosclerosis
-
Williams J.K., Shively C.A., Clarkson T.B. Determinants of coronary artery reactivity in premenopausal female cynomolgus monkeys with diet-induced atherosclerosis. Circulation. 90:1994;983-987.
-
(1994)
Circulation
, vol.90
, pp. 983-987
-
-
Williams, J.K.1
Shively, C.A.2
Clarkson, T.B.3
-
15
-
-
0345698562
-
Tailoring hormone therapy to patient's needs
-
Notelovitz M. Tailoring hormone therapy to patient's needs. Menopausal Med. 8:2000;1-5.
-
(2000)
Menopausal Med
, vol.8
, pp. 1-5
-
-
Notelovitz, M.1
-
16
-
-
0033399615
-
Significant differences in estradiol bioavailability from two similarly labelled estradiol matrix transdermal systems
-
Buch A.B., Shen L.Z., Kelly S.C., Russell D.A., Sahota R.S., Bixler C.A., et al. Significant differences in estradiol bioavailability from two similarly labelled estradiol matrix transdermal systems. Climacteric. 2:1999;248-253.
-
(1999)
Climacteric
, vol.2
, pp. 248-253
-
-
Buch, A.B.1
Shen, L.Z.2
Kelly, S.C.3
Russell, D.A.4
Sahota, R.S.5
Bixler, C.A.6
-
17
-
-
0031744033
-
Bioavailability of oestradiol from the Alora (0.1mg/day) oestradiol matrix transdermal delivery system compared with Estraderm (0.1 mg/day)
-
Bowen A.J., John V.A., Ramirez M.E., Good W.R. Bioavailability of oestradiol from the Alora (0.1mg/day) oestradiol matrix transdermal delivery system compared with Estraderm (0.1 mg/day). J Obstet Gynecol. 18:1998;575-580.
-
(1998)
J Obstet Gynecol
, vol.18
, pp. 575-580
-
-
Bowen, A.J.1
John, V.A.2
Ramirez, M.E.3
Good, W.R.4
-
18
-
-
0031655416
-
Testosterone deficiency: A key factor in the increased cardiovascular risk to women following hysterectomy or with natural aging?
-
Rako S. Testosterone deficiency a key factor in the increased cardiovascular risk to women following hysterectomy or with natural aging? J Womens Health. 7:1998;825-829.
-
(1998)
J Womens Health
, vol.7
, pp. 825-829
-
-
Rako, S.1
-
19
-
-
0033403242
-
A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles
-
Barrett-Conner E., Young R., Notelovitz M., Sullivan J., Wiita B., Yang H.M., et al. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles. J Reprod Med. 44:1999;1012-1020.
-
(1999)
J Reprod Med
, vol.44
, pp. 1012-1020
-
-
Barrett-Conner, E.1
Young, R.2
Notelovitz, M.3
Sullivan, J.4
Wiita, B.5
Yang, H.M.6
-
20
-
-
0028919957
-
Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality
-
Davis S.R., McCloud P., Strauss B.J., Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas. 21:1995;227-236.
-
(1995)
Maturitas
, vol.21
, pp. 227-236
-
-
Davis, S.R.1
McCloud, P.2
Strauss, B.J.3
Burger, H.4
-
21
-
-
0031756135
-
Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses
-
Sarrel P., Dobay B., Wiita B. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine responses. J Reprod Med. 43:1998;847-856.
-
(1998)
J Reprod Med
, vol.43
, pp. 847-856
-
-
Sarrel, P.1
Dobay, B.2
Wiita, B.3
-
22
-
-
0032991532
-
Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women
-
Stomati M., Rubino S., Spinetti A., Parrini D., Luisi S., Casarosa E., et al. Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women. Gynecol Endocrinol. 113:1999;15-25.
-
(1999)
Gynecol Endocrinol
, vol.113
, pp. 15-25
-
-
Stomati, M.1
Rubino, S.2
Spinetti, A.3
Parrini, D.4
Luisi, S.5
Casarosa, E.6
-
23
-
-
0030722649
-
Effect of postmenopausal estrogen replacement on circulating androgens
-
Casson P.R., Elkind-Hirsch K.E., Buster J.E., Hornsby P.J., Carson S.A., Snabes M.C. Effect of postmenopausal estrogen replacement on circulating androgens. Obstet Gynecol. 90:1997;995-998.
-
(1997)
Obstet Gynecol
, vol.90
, pp. 995-998
-
-
Casson, P.R.1
Elkind-Hirsch, K.E.2
Buster, J.E.3
Hornsby, P.J.4
Carson, S.A.5
Snabes, M.C.6
-
24
-
-
0035674284
-
Comparison of estrogen and androgen levels after oral estrogen replacement therapy
-
Slater C.C., Zhang C., Hodis H.N., Mack W.J., Boostanfar R., Shoupe D., et al. Comparison of estrogen and androgen levels after oral estrogen replacement therapy. J Reprod Med. 46:2001;1052-1056.
-
(2001)
J Reprod Med
, vol.46
, pp. 1052-1056
-
-
Slater, C.C.1
Zhang, C.2
Hodis, H.N.3
Mack, W.J.4
Boostanfar, R.5
Shoupe, D.6
-
25
-
-
0029803081
-
Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women
-
Stomati M., Hartmann B., Spinetti A., Mailand D., Rubino S., Albrecht A., et al. Effects of hormonal replacement therapy on plasma sex hormone-binding globulin, androgen and insulin-like growth factor-1 levels in postmenopausal women. J Endocrinol Invest. 19:1996;535-541.
-
(1996)
J Endocrinol Invest
, vol.19
, pp. 535-541
-
-
Stomati, M.1
Hartmann, B.2
Spinetti, A.3
Mailand, D.4
Rubino, S.5
Albrecht, A.6
-
26
-
-
0035063713
-
Effect of estrogen on serum DHEA in younger and older women and the relationship of DHEA to adiposity and gender
-
Kraemer R.R., Synovitz L.B., Gimpel T., Kraemer G.R., Johnson L.G., Castracane V.D. Effect of estrogen on serum DHEA in younger and older women and the relationship of DHEA to adiposity and gender. Metabolism. 50:2001;488-493.
-
(2001)
Metabolism
, vol.50
, pp. 488-493
-
-
Kraemer, R.R.1
Synovitz, L.B.2
Gimpel, T.3
Kraemer, G.R.4
Johnson, L.G.5
Castracane, V.D.6
-
27
-
-
0035698572
-
Long-term effects of continuous oral and transdermal estrogen replacement therapy on sex hormone binding globulin and free testosterone levels
-
Serin I.S., Ozcelik B., Basbug M., Aygen E., Kula M., Erez R. Long-term effects of continuous oral and transdermal estrogen replacement therapy on sex hormone binding globulin and free testosterone levels. Eur J Obstet Gynecol Reprod Biol. 99:2001;222-225.
-
(2001)
Eur J Obstet Gynecol Reprod Biol
, vol.99
, pp. 222-225
-
-
Serin, I.S.1
Ozcelik, B.2
Basbug, M.3
Aygen, E.4
Kula, M.5
Erez, R.6
-
28
-
-
0344835624
-
An ultra-sensitive radioimmunoassay for estradiol [abstract no. 1659]
-
Mistry JS, Khaja N, Savjani G, Castracane VD, Tawwater B, Gimpel T. An ultra-sensitive radioimmunoassay for estradiol [abstract no. 1659]. Clin Chem 1998;44(S6):151.
-
(1998)
Clin Chem
, vol.44
, Issue.6 S
, pp. 151
-
-
Mistry, J.S.1
Khaja, N.2
Savjani, G.3
Castracane, V.D.4
Tawwater, B.5
Gimpel, T.6
-
29
-
-
0031886378
-
Rapid, convenient radioimmunoassay of estrone sulfate
-
Ranadive G., Mistry J., Damodaran K., Khosravi M.J., Diamandi A., Gimpel T., et al. Rapid, convenient radioimmunoassay of estrone sulfate. Clin Chem. 44:1998;244-249.
-
(1998)
Clin Chem
, vol.44
, pp. 244-249
-
-
Ranadive, G.1
Mistry, J.2
Damodaran, K.3
Khosravi, M.J.4
Diamandi, A.5
Gimpel, T.6
-
30
-
-
0029812296
-
Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol
-
Setnikar I., Rovati L.C., Vens-CaPell B., Hilgenstock C. Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol. Arzneimittelforschung. 46:1996;766-773.
-
(1996)
Arzneimittelforschung
, vol.46
, pp. 766-773
-
-
Setnikar, I.1
Rovati, L.C.2
Vens-CaPell, B.3
Hilgenstock, C.4
-
31
-
-
0027531009
-
Menopause and hormone replacement therapy
-
Speroff L. Menopause and hormone replacement therapy. Clin Geriatr Med. 9:1993;33-55.
-
(1993)
Clin Geriatr Med
, vol.9
, pp. 33-55
-
-
Speroff, L.1
-
32
-
-
0015983622
-
Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer
-
Judd H.L., Lucas W.E., Yen S.S. Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol. 118:1974;793-798.
-
(1974)
Am J Obstet Gynecol
, vol.118
, pp. 793-798
-
-
Judd, H.L.1
Lucas, W.E.2
Yen, S.S.3
-
34
-
-
0034750212
-
The postmenopausal ovary is not a major androgen-producing gland
-
Couzinet B., Meduri G., Lecce M., Young J., Brailly S., Loosfelt H., et al. The postmenopausal ovary is not a major androgen-producing gland. J Clin Endocrinol Metab. 86:2001;5060-5066.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 5060-5066
-
-
Couzinet, B.1
Meduri, G.2
Lecce, M.3
Young, J.4
Brailly, S.5
Loosfelt, H.6
-
35
-
-
0003984768
-
-
New Jersey: Medical Economics Company
-
Physicians' desk reference. 2002;3373 Medical Economics Company, New Jersey.
-
(2002)
Physicians' Desk Reference
, pp. 3373
-
-
|